The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model

Ventelou, Bruno; Arrighi, Yves; Greener, Robert; Lamontagne, Erik; Carrieri, Patrizia; Moatti, Jean-Paul
April 2012
PLoS ONE;Apr2012, Vol. 7 Issue 4, p1
Academic Journal
Aim: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative scenarios for the macroeconomic performance of countries. Methods: We used a micro-simulation model based on individuals aged 15-49 selected from nationally representative surveys (DHS for Cameroon, Tanzania and Swaziland) to compare alternative scenarios : 1-freezing of ART programs to current levels of access, 2- universal access (scaling up to 100% coverage by 2015, with two variants defining ART eligibility according to previous or current WHO guidelines). We introduced an "artificial" ageing process by programming methods. Individuals could evolve through different health states: HIV negative, HIV positive (with different stages of the syndrome). Scenarios of ART procurement determine this dynamics. The macroeconomic impact is obtained using sample weights that take into account the resulting age-structure of the population in each scenario and modeling of the consequences on total growth of the economy. Results: Increased levels of ART coverage result in decreasing HIV incidence and related mortality. Universal access to ART has a positive impact on workers' productivity; the evaluations performed for Swaziland and Cameroon show that universal access would imply net cost-savings at the scale of the society, when the full macroeconomic consequences are introduced in the calculations. In Tanzania, ART access programs imply a net cost for the economy, but 70% of costs are covered by GDP gains at the 2034 horizon, even in the extended coverage option promoted by WHO guidelines initiating ART at levels of 350 cc/mm3 CD4 cell counts. Conclusion: Universal Access ART scaling-up strategies, which are more costly in the short term, remain the best economic choice in the long term. Renouncing or significantly delaying the achievement of this goal, due to "legitimate" short term budgetary constraints would be a misguided choice.


Related Articles

  • HIV/AIDS.  // Background Notes on Countries of the World: South Africa;1/30/2012, p7 

    The article presents information on HIV rates in South Africa, as well as the country's environmental protection efforts. Having one of the highest rates of HIV prevalence in the world, South Africa implemented a 2007 to 2011 national strategic plan that provides the structure for a...

  • Guidelines for antiretroviral therapy in adults. Meintjes, Graeme; Conradie, Francesca; Goemaere, Eric; Hefer, Eric; Johnson, Dave; Mathe, Moeketsi; Moosa, Yunus; Osih, Regina; Rossouw, Theresa; van Cutsem, Gilles; Variava, Ebrahim; Venter, Francois; Spencer, Dave // Southern African Journal of HIV Medicine;Sep2012, Vol. 13 Issue 3, p114 

    These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in January 2008. Since the release of the previous guidelines, the scale-up of antiretroviral therapy (ART) in Southern Africa has continued to grow. Cohort studies from the region show...

  • HIV treatment prevents transmission of HIV.  // Africa Health;May2011, Vol. 33 Issue 4, p11 

    The article discusses the report from the US National Institutes of Health which found that an effective antiretroviral therapy regimen for HIV-positive person could prevent the risk of transmitting the virus to their uninfected sexual partner.

  • INFANT BREASTFEEDING AND HIV: A REVIEW ARTICLE. Nandini, D. B.; Deepak, B. S. // Annals & Essences of Dentistry;Apr-Jun2010, Vol. 2 Issue 2, p82 

    Human Immunodeficiency Virus (HIV) and infant feeding is a complex issue, and there are still significant knowledge gaps, including whether antiretroviral prophylaxis for an Infant during breastfeeding, or antiretroviral treatment for breastfeeding mother, are safe and effective in reducing HIV...

  • Factors affecting default among pre-ART patients in Eastern Uttar Pradesh. Kansal, Sangeeta; Sundar, Shyam; Rai, Madhukar; Tiwary, Narendra Kumar; Chakravarty, Jaya // BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1 

    The article presents a study on the factors affecting default among pre-antiretroviral therapy (ART) patients in Eastern Uttar Pradesh, India. The mentions that the rention of HIV patients in the is a challenge in preventing the development of the disease. They note that there is a significant...

  • Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study. Teshome, Wondu; Tefera, Ambachew // BMC Immunology;9/17/2015, Vol. 16 Issue 1, p1 

    Background: Timely detection of treatment failure with subsequent switch to second-line regimen reduces mortality among HIV infected people on antiretroviral therapy (ART). This paper aims to investigate the detection of immunological treatment failure and switch rate to second line regimen in...

  • The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior? Carr, Andrew; Hoy, Jennifer; Pozniak, Anton // PLoS Medicine;Jul2012, Vol. 9 Issue 7, p1 

    An essay is presented on conducting clinical trials for antiretroviral therapy (ART). It discusses two types of clinical studies for the efficacy of ART performed in patients receiving effective ART and with undetectable plasma HIV. It explores trials that have been conducted because of the high...

  • HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment-State of the Art and Future Directions. Meyer-Rath, Gesine; Over, Mead // PLoS Medicine;Jul2012, Vol. 9 Issue 7, p1 

    Policy discussions about the feasibility of massively scaling up antiretroviral therapy (ART) to reduce HIV transmission and incidence hinge on accurately projecting the cost of such scale-up in comparison to the benefits from reduced HIV incidence and mortality. We review the available...

  • HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes. Delva, Wim; Eaton, Jeffrey W.; Fei Meng; Fraser, Christophe; White, Richard G.; Vickerman, Peter; Boily, Marie-Claude; Hallett, Timothy B. // PLoS Medicine;Jul2012, Vol. 9 Issue 7, p1 

    Until now, decisions about how to allocate ART have largely been based on maximising the therapeutic benefit of ART for patients. Since the results of the HPTN 052 study showed efficacy of antiretroviral therapy (ART) in preventing HIV transmission, there has been increased interest in the...


Read the Article

Other Topics